Peter A Thompson Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Peter A Thompson.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Peter A Thompson. Peter A Thompson is Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in ProNAi Therapeutics Inc ($DNAI) and President and CEO in Trubion Pharmaceuticals, Inc ($TRBN) and President, CEO & Treasurer in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Synthorx, Inc. ($THOR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Prevail Therapeutics Inc. ($PRVL) and Director in Edgewise Therapeutics, Inc. ($EWTX).

Latest Insider Trading Transactions of Peter A Thompson

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADAP, ALPN, CRVS, DBTX, EWTX, PMVP, PRVL, RPBIF, SRRA, SBTX, THOR, TRBN

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 31 2021	EWTX	Edgewise Therapeut ...	Thompson Peter A.	Director	Option Exercise	C	0.00	272,724	0	0
Mar 31 2021	EWTX	Edgewise Therapeut ...	Thompson Peter A.	Director	Option Exercise	C	0.00	1,668,350	0	0
Mar 31 2021	EWTX	Edgewise Therapeut ...	Thompson Peter A.	Director	Option Exercise	C	0.00	1,301,626	0	0
Mar 31 2021	EWTX	Edgewise Therapeut ...	Thompson Peter A.	Director	Option Exercise	C	0.00	1,572,960	0	0
Mar 31 2021	EWTX	Edgewise Therapeut ...	Thompson Peter A.	Director	Option Exercise	C	0.00	8,187,100	0	0
Mar 31 2021	EWTX	Edgewise Therapeut ...	Thompson Peter A.	Director	Buy	P	16.00	312,500	5,000,000	13,359,456	13 M to 13.4 M (+2.40 %)
Mar 31 2021	EWTX	Edgewise Therapeut ...	Thompson Peter A.	Director	Buy	P	16.00	46,875	750,000	319,599	272.7 K to 319.6 K (+17.19 %)
Mar 31 2021	EWTX	Edgewise Therapeut ...	Thompson Peter A.	Director	Buy	C	0.00	272,724	0	272,724	0 to 272.7 K
Mar 31 2021	EWTX	Edgewise Therapeut ...	Thompson Peter A.	Director	Buy	C	0.00	12,730,036	0	13,046,956	316.9 K to 13 M (+4,016.80 %)
Feb 19 2021	DBTX	Decibel Therapeuti ...	Thompson Peter A.	Director	Option Exercise	C	0.00	1,158,412	0	0
Feb 19 2021	DBTX	Decibel Therapeuti ...	Thompson Peter A.	Director	Option Exercise	C	0.00	1,737,619	0	0
Feb 19 2021	DBTX	Decibel Therapeuti ...	Thompson Peter A.	Director	Option Exercise	C	0.00	14,480,162	0	0
Feb 19 2021	DBTX	Decibel Therapeuti ...	Thompson Peter A.	Director	Buy	P	18.00	555,566	10,000,188	883,418	327.9 K to 883.4 K (+169.46 %)
Feb 19 2021	DBTX	Decibel Therapeuti ...	Thompson Peter A.	Director	Buy	P	18.00	1,111,100	19,999,800	3,843,206	2.7 M to 3.8 M (+40.67 %)
Feb 19 2021	DBTX	Decibel Therapeuti ...	Thompson Peter A.	Director	Buy	C	0.00	218,568	0	218,568	0 to 218.6 K
Feb 19 2021	DBTX	Decibel Therapeuti ...	Thompson Peter A.	Director	Buy	C	0.00	327,852	0	327,852	0 to 327.9 K
Feb 19 2021	DBTX	Decibel Therapeuti ...	Thompson Peter A.	Director	Buy	C	0.00	2,732,106	0	2,732,106	0 to 2.7 M
Feb 19 2021	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.50	1,285,714	4,499,999	8,053,298	6.8 M to 8.1 M (+19.00 %)
Jan 26 2021	PRVL	Prevail Therapeuti ...	Thompson Peter A.	Director	Option Exercise	D	16.98	17,000	288,660	0
Jan 26 2021	PRVL	Prevail Therapeuti ...	Thompson Peter A.	Director	Sell	U	0.00	13,822,463	0	0	13.8 M to 0 (-100.00 %)
Dec 30 2020	ALPN	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Sell	S	14.25	600,000	8,550,000	3,070,955	3.7 M to 3.1 M (-16.34 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	3,918,279	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	9,259,259	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	3,918,279	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	12,857,142	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	9,259,259	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	P	21.00	952,377	19,999,917	952,377	0 to 952.4 K
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	12,857,142	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	1,055,287	0	7,519,188	6.5 M to 7.5 M (+16.33 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	P	21.00	952,377	19,999,917	952,377	0 to 952.4 K
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	2,493,741	0	6,463,901	4 M to 6.5 M (+62.81 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	1,055,287	0	7,519,188	6.5 M to 7.5 M (+16.33 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	3,462,737	0	3,970,160	507.4 K to 4 M (+682.42 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	2,493,741	0	6,463,901	4 M to 6.5 M (+62.81 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	P	21.00	238,100	5,000,100	507,423	269.3 K to 507.4 K (+88.41 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	3,462,737	0	3,970,160	507.4 K to 4 M (+682.42 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	P	21.00	238,100	5,000,100	507,423	269.3 K to 507.4 K (+88.41 %)
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Option Exercise	C	0.00	114,039	0	0
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Option Exercise	C	0.00	380,133	0	0
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Option Exercise	C	0.00	518,191	0	0
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Option Exercise	C	0.00	1,076,891	0	0
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Option Exercise	C	0.00	4,025,076	0	0
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Buy	P	18.00	475,000	8,550,000	475,000	0 to 475 K
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Buy	C	0.00	114,039	0	114,039	0 to 114 K
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Buy	C	0.00	380,133	0	6,475,291	6.1 M to 6.5 M (+6.24 %)
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Buy	C	0.00	518,191	0	6,095,158	5.6 M to 6.1 M (+9.29 %)
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Buy	C	0.00	1,076,891	0	5,576,967	4.5 M to 5.6 M (+23.93 %)
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Buy	C	0.00	4,025,076	0	4,500,076	475 K to 4.5 M (+847.38 %)
Sep 29 2020	PMVP	PMV Pharmaceutical ...	Thompson Peter A.	Director	Buy	P	18.00	475,000	8,550,000	475,000	0 to 475 K
Jun 19 2020	PRVL	Prevail Therapeuti ...	Thompson Peter A.	Director	Option Exercise	A	16.98	17,000	288,660	17,000
Jun 12 2020	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	3.27	15,000	49,050	15,000
Mar 23 2020	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	2.00	15,000	30,000	15,000
Jan 24 2020	THOR	Synthorx, Inc.	Thompson Peter A.	Director	Option Exercise	D	12.40	15,335	190,154	0
Jan 24 2020	THOR	Synthorx, Inc.	Thompson Peter A.	Director	Option Exercise	D	11.00	30,000	330,000	0
Jan 24 2020	THOR	Synthorx, Inc.	Thompson Peter A.	Director	Sell	U	68.00	5,316,355	361,512,140	0	5.3 M to 0 (-100.00 %)
Jan 06 2020	ALPN	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Option Exercise	A	3.62	7,650	27,718	7,650
Aug 08 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.51	142,656	500,723	6,767,584	6.6 M to 6.8 M (+2.15 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.91	59,243	231,640	6,624,928	6.6 M to 6.6 M (+0.90 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.72	565,178	2,102,462	6,565,685	6 M to 6.6 M (+9.42 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.34	32,923	109,963	6,000,507	6 M to 6 M (+0.55 %)
Jun 26 2019	PRVL	Prevail Therapeuti ...	Thompson Peter A.	Director	Option Exercise	C	0.00	1,011,499	0	0
Jun 26 2019	PRVL	Prevail Therapeuti ...	Thompson Peter A.	Director	Option Exercise	C	0.00	3,099,612	0	0
Jun 26 2019	PRVL	Prevail Therapeuti ...	Thompson Peter A.	Director	Option Exercise	C	0.00	6,399,000	0	0
Jun 26 2019	PRVL	Prevail Therapeuti ...	Thompson Peter A.	Director	Buy	P	17.00	882,352	14,999,984	13,822,463	12.9 M to 13.8 M (+6.82 %)
Jun 26 2019	PRVL	Prevail Therapeuti ...	Thompson Peter A.	Director	Buy	C	0.00	10,510,111	0	12,940,111	2.4 M to 12.9 M (+432.51 %)
Jun 24 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	3.61	15,000	54,150	15,000
Jun 10 2019	THOR	Synthorx, Inc.	Thompson Peter A.	Director	Option Exercise	A	12.40	15,335	190,154	15,335
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Option Exercise	P	0.00	145,251	0	145,251
Jan 23 2019	ALPN	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Buy	P	5.37	372,439	1,999,997	3,670,955	3.3 M to 3.7 M (+11.29 %)
Jan 04 2019	ALPN	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Option Exercise	A	4.09	7,650	31,289	7,650
Dec 13 2018	THOR	Synthorx, Inc.	Thompson Peter A.	Director	Option Exercise	C	0.00	6,333,206	0	0
Dec 13 2018	THOR	Synthorx, Inc.	Thompson Peter A.	Director	Buy	P	11.00	1,363,636	14,999,996	5,316,355	4 M to 5.3 M (+34.50 %)
Dec 13 2018	THOR	Synthorx, Inc.	Thompson Peter A.	Director	Buy	C	0.00	3,952,719	0	3,952,719	0 to 4 M
Dec 07 2018	THOR	Synthorx, Inc.	Thompson Peter A.	Director	Option Exercise	A	11.00	30,000	330,000	30,000
Jun 25 2018	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	12.50	15,000	187,500	15,000
Jun 06 2018	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Sell	S	13.49	1,600	21,584	4,901,310	4.9 M to 4.9 M (-0.03 %)
Jun 06 2018	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Sell	S	13.57	17,100	232,047	4,902,910	4.9 M to 4.9 M (-0.35 %)
Jun 01 2018	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Sell	S	13.49	50,000	674,500	4,920,010	5 M to 4.9 M (-1.01 %)
Jun 01 2018	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Sell	S	13.52	121,000	1,635,920	4,970,010	5.1 M to 5 M (-2.38 %)
May 16 2018	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Sell	S	13.50	10,300	139,050	5,091,010	5.1 M to 5.1 M (-0.20 %)
Mar 29 2018	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Sell	S	11.53	31,983	368,764	5,101,310	5.1 M to 5.1 M (-0.62 %)
Mar 29 2018	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Sell	S	11.50	1,016,084	11,684,966	5,133,293	6.1 M to 5.1 M (-16.52 %)
Mar 14 2018	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	8.50	588,235	4,999,998	5,967,584	5.4 M to 6 M (+10.94 %)
Jan 04 2018	NVLS	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Option Exercise	A	11.31	7,650	86,522	7,650
Jul 26 2017	NVLS	ALPINE IMMUNE SCIE ...	Thompson Peter A.	Director	Grant	A	0.00	3,298,516	0	3,298,516	0 to 3.3 M
Jul 03 2017	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Option Exercise	A	0.75	223,779	167,834	223,779
Jun 09 2017	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	9.70	15,000	145,500	15,000
Mar 28 2017	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Buy	P	4.20	1,190,476	4,999,999	6,149,377	5 M to 6.1 M (+24.01 %)
Dec 01 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Option Exercise	D	0.85	5,000	4,250	0
Dec 01 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Option Exercise	D	0.92	5,000	4,600	0
Dec 01 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Option Exercise	D	1.43	5,000	7,150	0
Dec 01 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Option Exercise	D	3.10	20,000	62,000	0
Dec 01 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Option Exercise	D	1.02	20,000	20,400	0
Dec 01 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Option Exercise	D	2.20	166,666	366,665	0
Dec 01 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Sell	J	0.00	2,149,902	0	0	2.1 M to 0 (-100.00 %)
Dec 01 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Sell	J	0.00	34,291	0	0	34.3 K to 0 (-100.00 %)
Dec 01 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Sell	J	0.00	3,604,266	0	0	3.6 M to 0 (-100.00 %)
Dec 01 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Sell	J	0.00	96,884	0	0	96.9 K to 0 (-100.00 %)
Aug 12 2016	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Option Exercise	A	1.27	186,142	236,400	186,142
Jun 27 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.99	900	11,691	5,379,349	5.4 M to 5.4 M (+0.02 %)
Jun 27 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.92	100	1,292	5,378,449	5.4 M to 5.4 M (0.00 %)
Jun 21 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.87	26,083	335,688	5,378,349	5.4 M to 5.4 M (+0.49 %)
Jun 21 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.48	12,300	153,504	5,352,266	5.3 M to 5.4 M (+0.23 %)
Jun 20 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Buy	P	0.56	331,225	185,486	2,149,902	1.8 M to 2.1 M (+18.21 %)
Jun 20 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Buy	P	0.56	5,294	2,965	34,291	29 K to 34.3 K (+18.26 %)
Jun 20 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Buy	P	0.56	556,339	311,550	3,604,266	3 M to 3.6 M (+18.25 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.04	5,000	60,200	5,339,966	5.3 M to 5.3 M (+0.09 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	11.94	5,000	59,700	5,334,966	5.3 M to 5.3 M (+0.09 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.71	10,000	127,100	5,329,966	5.3 M to 5.3 M (+0.19 %)
Jun 13 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.98	20,000	259,600	5,319,966	5.3 M to 5.3 M (+0.38 %)
Jun 13 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.95	30,000	388,500	5,299,966	5.3 M to 5.3 M (+0.57 %)
May 25 2016	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Buy	P	10.48	518,400	5,432,832	29,753,404	29.2 M to 29.8 M (+1.77 %)
May 25 2016	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Buy	P	10.40	1,191,600	12,392,640	29,235,004	28 M to 29.2 M (+4.25 %)
May 25 2016	ADAP	Adaptimmune Therap ...	Thompson Peter A.	Director	Buy	P	10.04	2,400	24,096	28,043,404	28 M to 28 M (+0.01 %)
May 24 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	13.09	4,716	61,732	5,269,966	5.3 M to 5.3 M (+0.09 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.75	61	778	5,265,250	5.3 M to 5.3 M (0.00 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.11	2,539	30,747	5,265,189	5.3 M to 5.3 M (+0.05 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	11.55	4,200	48,510	5,262,650	5.3 M to 5.3 M (+0.08 %)
Mar 28 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Option Exercise	A	0.85	5,000	4,250	5,000
Mar 28 2016	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Grant	A	0.00	37,058	0	96,884	59.8 K to 96.9 K (+61.94 %)
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	C	0.00	713,776	0	0
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	C	0.00	3,994,674	0	0
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	15.00	550,000	8,250,000	5,258,450	4.7 M to 5.3 M (+11.68 %)
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	C	0.00	713,776	0	4,708,450	4 M to 4.7 M (+17.87 %)
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	C	0.00	3,994,674	0	3,994,674	0 to 4 M
Mar 24 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	15.00	30,000	450,000	30,000
Jul 21 2015	DNAI	ProNAi Therapeutic ...	Thompson Peter A.	Director	Option Exercise	C	0.00	1,725,790	0	0
Jul 21 2015	DNAI	ProNAi Therapeutic ...	Thompson Peter A.	Director	Buy	P	17.00	175,000	2,975,000	1,989,949	1.8 M to 2 M (+9.64 %)
Jul 21 2015	DNAI	ProNAi Therapeutic ...	Thompson Peter A.	Director	Buy	J	5.22	89,159	464,964	1,814,949	1.7 M to 1.8 M (+5.17 %)
Jul 21 2015	DNAI	ProNAi Therapeutic ...	Thompson Peter A.	Director	Buy	C	0.00	1,725,790	0	1,725,790	0 to 1.7 M
May 21 2015	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Grant	A	0.00	10,511	0	59,826	49.3 K to 59.8 K (+21.31 %)
Mar 23 2015	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Option Exercise	A	0.92	5,000	4,600	5,000
Mar 23 2015	RPBIF	RESPONSE BIOMEDICA ...	Thompson Peter A.	Director	Grant	A	0.00	8,860	0	49,315	40.5 K to 49.3 K (+21.90 %)
Aug 28 2009	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Option Exercise	A	1.33	40,000	53,200	40,000
May 26 2009	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Option Exercise	M	0.31	1,913	600	0
May 26 2009	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Option Exercise	M	0.31	26,892	8,431	0
May 26 2009	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Option Exercise	M	0.31	80,678	25,293	0
May 26 2009	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Option Exercise	M	0.31	16,904	5,299	0
May 26 2009	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Buy	M	0.31	1,913	600	385,419	383.5 K to 385.4 K (+0.50 %)
May 26 2009	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Buy	M	0.31	26,892	8,431	383,506	356.6 K to 383.5 K (+7.54 %)
May 26 2009	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Buy	M	0.31	80,678	25,293	356,614	275.9 K to 356.6 K (+29.24 %)
May 26 2009	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Buy	M	0.31	16,904	5,299	275,936	259 K to 275.9 K (+6.53 %)
Jan 30 2009	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President, CEO & Tr ...	Option Exercise	A	1.33	80,000	106,400	80,000
Mar 11 2008	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President, CEO & Tr ...	Option Exercise	A	8.98	90,000	808,200	90,000
Nov 20 2007	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Buy	P	10.11	392	3,963	259,032	258.6 K to 259 K (+0.15 %)
Nov 20 2007	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Buy	P	10.08	227	2,288	258,640	258.4 K to 258.6 K (+0.09 %)
Nov 20 2007	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Buy	P	10.06	100	1,006	258,413	258.3 K to 258.4 K (+0.04 %)
Nov 20 2007	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Buy	P	10.13	2,526	25,588	258,313	255.8 K to 258.3 K (+0.99 %)
Nov 20 2007	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Buy	P	10.01	300	3,003	255,787	255.5 K to 255.8 K (+0.12 %)
Nov 20 2007	TRBN	Trubion Pharmaceut ...	Thompson Peter A	President and CEO	Buy	P	10.02	100	1,002	255,487	255.4 K to 255.5 K (+0.04 %)

Page: 1 2 next >